These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11503777)

  • 41. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(107):33362-81. PubMed ID: 12785379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beverages: bottled water. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 May; 74(102):25651-65. PubMed ID: 19507330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood vessels recovered with organs and intended for use in organ transplantation. Direct final rule.
    Food and Drug Administration, Health Resources and Services Administration, (HHS)
    Fed Regist; 2006 May; 71(92):27606-10. PubMed ID: 16696153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Mar; 72(43):9849-52. PubMed ID: 17447341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Aug; 64(160):45366-74. PubMed ID: 10558597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beverages: bottled water. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Mar; 68(41):9873-82. PubMed ID: 12625359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Aug; 81(169):60169-224. PubMed ID: 27580511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beverages: bottled water. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Jun; 70(110):33694-701. PubMed ID: 15945150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
    Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Jan; 64(19):4535-40. PubMed ID: 10557608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(24):5696-9. PubMed ID: 22359804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New US agent requirements.
    Donawa M
    Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66636. PubMed ID: 11503697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Mar; 74(43):9759-65. PubMed ID: 19418638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.